Seeking Alpha

Gilead heads Citi's 20 best stocks in America

  • Citi analysts post their list of 50 top Buy-rated stocks with a market cap of at least $3B, at least a top-three market share in a third of their businesses, and a global reach as measured by significant revenue outside of their home market; Business Insider highlights 20 according to estimated total return.
  • Gilead Sciences (GILD) tops the list with a 45.4% ETR, and Citi believes GILD will generate a significant amount of cash and will buy back stock, engage in product and company acquisitions to grow its pipeline, and potentially start providing a dividend in 2-3 years.
  • Rounding out the top 20: FB, BX, V, CERN, FLT, BA, MA, LVS, SBUX, MJN, GOOG, EBAY, BIIB, AXP, HOG, VFC, PII, VMC, FTI.
Comments (15)
  • Archman Investor
    , contributor
    Comments (2350) | Send Message
     
    Good news! I'm sure I don't own a single one. That means I will be fine.
    21 Apr, 10:37 AM Reply Like
  • eh.geee@gmail
    , contributor
    Comments (43) | Send Message
     
    It also creates a practically infallible list of shorts. : )
    21 Apr, 11:37 AM Reply Like
  • eftvox
    , contributor
    Comments (112) | Send Message
     
    uh oh...i own a few. crap
    21 Apr, 10:59 AM Reply Like
  • mjtroll1
    , contributor
    Comments (677) | Send Message
     
    am long the gild/ibb pair..hope they are right
    21 Apr, 11:18 AM Reply Like
  • JAC92651
    , contributor
    Comments (67) | Send Message
     
    I think GILD is a win.
    21 Apr, 12:12 PM Reply Like
  • The Growth Investor
    , contributor
    Comments (148) | Send Message
     
    Interesting that they list three credit card companies.
    21 Apr, 12:15 PM Reply Like
  • lflescher
    , contributor
    Comments (5) | Send Message
     
    why does gild plummet. and plummet
    21 Apr, 12:30 PM Reply Like
  • duhaus
    , contributor
    Comments (308) | Send Message
     
    I'll file this one under "is that good or bad?"
    21 Apr, 01:07 PM Reply Like
  • Piptief
    , contributor
    Comments (275) | Send Message
     
    AAPL not in the list. Thank goodness!
    21 Apr, 05:06 PM Reply Like
  • Teriee
    , contributor
    Comments (35) | Send Message
     
    Citi is toast
    21 Apr, 05:19 PM Reply Like
  • fchase1938
    , contributor
    Comment (1) | Send Message
     
    If Gilead Sciences (GILD) is the best, according to Business Insider, of Citi's best then why does Schwab rate it as a D? ("GILD Underperform as of 04/18/2014")
    21 Apr, 08:19 PM Reply Like
  • RevolutionaryDoc
    , contributor
    Comments (5) | Send Message
     
    People who do not see the vast potential of Gilead's current drugs and pipeline simply have never taken care of a sick person. Gilead will change the way we treat many diseases in the future. Curing Hep C and Aids is just the tip of the iceberg.
    With their foresight, bank roll and scientific assets, I expect GILD will focus on the big killers soon ( cardiovascular disease and diabetes) with spectacular results . GILD will soon buy little known biotechs with breakthrough/game changing drug potential and change the way we treat patients. Print this silly posting along with Gilead's current stock price and save it. Re- read it in 4 to 5 years and look back on the exponential increase in its stock price. Gilead under $100 is a bargain.
    22 Apr, 06:28 AM Reply Like
  • Teriee
    , contributor
    Comments (35) | Send Message
     
    As a retired ICU Rn and Nurse anesthetist, I have seen more than I could ever have imagined during my 45 year working history. Revolutionary Doc, you are so correct in all that you've said. I have GILD in my retirement portfolio. Hospitals, as you may guess offer very little in terms of retirement and NO group health insurance plans...so isn't it ironic that the very patients I stayed up allnight caring for are benefiting from a cure now...and the company that is providing this wonderful cure is also helping this very tired and retired nurse a managable retirement. Insurance companies know the benefit of paying the 84,000.00 for the cure...Congress and the Express Scripts CEO could donate HALF of their income or benefits value and pay for the bulk of the cost. IMO , Express Scripts is worthless and and an unnecessary cost to the public. The masses will get smart eventually.
    22 Apr, 09:22 AM Reply Like
  • tennis44
    , contributor
    Comments (42) | Send Message
     
    Bx belongs at the top, a very smart mgt and a winner
    24 Apr, 02:09 AM Reply Like
  • Snoopy1
    , contributor
    Comments (1100) | Send Message
     
    Most of the list are quality businesses, but Citi is too optimistic on target valuation, especially V, MA, VFC and SBUX, all of which I own.
    24 Apr, 05:37 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|